CB vs PLRX · P/E 14, rev $59.40B vs $77.3M cap
Chubb Ltd (CB) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the CB and PLRX stock pages for the full models.
Not investment advice.